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The pathogenesis of the severe complications of dengue virus infections, dengue
hemorrhagic fever (DHF)' and dengue shock syndrome (DSS), is one of the most
important subjects to be elucidated in dengue virus research. Epidemiological studies
have shown that DHF/DSS is much more commonly observed during secondary
dengue infections than primary infections (1, 2), and secondary infections are caused
by virus strains of a different serotype than the dengue virus that caused the primary
infection (1). It has been reported that antidengue antibodies at subneutralizing con-
centrations augment dengue virus infection of Fcy receptor-positive cells, such as
monocytes (3, 4) . Dengue antigen-positive monocytic cells are found in patients with
DHF/DSS (5, 6) and dengue virus has been recovered from the monocytic fraction
of PBMC obtained from infected patients (7). Based on these observations it has
been hypothesized that dengue serotype crossreactive antibodies may increase the
number of dengue virus-infected monocytes during secondary infections, and lysis
of these dengue-infected monocytes by immune cytolysis may lead to the pathogen-
esis of DHF/DSS (1, 8). Despite this hypohesis, dengue virus-specific T lymphocyte
responses in humans have not been defined. We recently reported the presence of
dengue antigen-specific CD4+ T cells in bulk cultures oflymphocytes from dengue
antibody-positive donors, which proliferate and produce IFN-y after stimulation
with dengue antigens (9). In addition, we reported that the IFN-y produced was
able to augment dengue virus infection of monocytic cells in the presence of anti-
dengue antibody (10). To further elucidate the role ofT lymphocytes in dengue virus
infections, we have begun to analyze the serotype specificity, IFN-y production, and
cytotoxic activity of dengue antigen-specific T lymphocytes at the clonal level, using
PBL of a donor who was known to have been infected with dengue 3 virus. All the
clones established have a CD3' CD4+ CD8 - phenotype, and most of the clones are
serotype crossreactive. All but one of these serotype crossreactive clones produce
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IFN--y after stimulation with dengue virus antigens of heterologous serotypes, and
the same clones lyse dengue 2 virus-infected autologous lymphoblastoid cells. These
results suggest that dengue serotype crossreactive CD4* T lymphocytes may con-
tribute to the pathogenesis of DHF/DSS by producing IFN-y and lysing dengue
virus-infected autologous cells during secondary infections.
Materials and Methods
Human PBMC.
￿
Peripheral blood specimens were obtained from a donor who had been
immunized with yellow fever vaccine 2 yr earlier and was infected with dengue 3 virus, strain
CH53489, 1 yr previously (11). PBMC were also obtained from a donor in Aruba who had
been infected with dengue 1 virus 4 mo previously, and from a healthy blood bank donor
from Massachusetts who did not have detectable antibodies to dengue virus as determined
by a plaque reduction neutralization test (12). PBMC were separated by a Ficoll-Hypaque
density gradient centrifugation method (13). Cells were resuspended at the concentration
of 10'/ml in RPMI containing 10% FCS (Gibco Laboratories, Grand Island, NY) and 10%
DMSO (Fisher Scientific Co., Pittsburgh, PA), and were cryopreserved until use (12).
Viruses.
￿
The dengue virus strains used were type 1, the Hawaii strain; type 2, the New
Guinea C strain; type 3, the CH53489 strain; and type 4, the 814669 strain. Dengue virus
types 1 and 2 were supplied by Dr. Walter E. Brandt of Walter Reed Army Institute of Re-
search, Washington DC, type 3 was supplied by Dr. Bruce L. Innis of the Armed Forces Re-
search Institute of Medical Science, Bangkok, Thailand, and type 4 was supplied by Jack
McCown of the Walter Reed Army Institute of Research.
Preparation ofDengueAntigens.
￿
Dengue antigens were prepared using dengue virus-infected
Vero cells as previously reported (9). Vero cellswere infected with dengue virus at an approx-
imate multiplicity of infection (m.o.i.) of 1 plaque-forming unit (PFU)/cell, and cultured in
MEM containing 2% FCS. When 50% of the monolayer developed cytopathic effects, the
cells were removed using cell scrapers (Costar, Cambridge, MA), washed three times with
PBS at 4°C, treated with 0.025% glutaraldehyde (Sigma Chemical Co., St. Louis, MO) in
PBS for 15 min at 4°C, washed again three times with PBS, and resuspended in RPMI. They
were then sonicated with a sonic dismembrator (Fisher ScientificCo.) and centrifuged at 2,500
rpm for 10 min. The supernatant fluids were collected and used as dengue antigens. Control
antigens were prepared in a similar manner using uninfected Vero cells. 3 ml of antigen was
obtained from 15 75-cm2 flasks (Costar) of confluent Vero cells.
Induction ofProliferative Responses ofPBMC.
￿
Proliferative responses of PBMC were detected
as previously reported (9). 2 x 105 PBMC were cultured with dengue antigens diluted 1 :30
in 0.2 ml RPMI containing 10% humanAB serum (Hazleton Research Products, Inc., Lenexa,
KS) and 5 x 10-5 M 2-ME (Sigma Chemical Co.) in 96-well round-bottomed plates (Costar)
at 37°C for 6 d. Cells were pulsed with 1 .25 pCi of [3H]TdR for 8 h before harvest. Cells
were harvested using a Titertek Multiharvester (Skatron, Inc., Sterling, VA) and [3H]TdR
incorporation was counted in a liquid scintillation counter (Packard Instrument Co., Inc.,
Downers Grove, IL).
Establishment ofAntigen-sped T Cell Clones Using a Limited Dilution Method
￿
4 x 105 PBMC
were cultured with dengue 3 antigen at a final dilution of 1:30 in 0.2 ml RPMI containing
10% human AB serum in 96-well round-bottomed plates for 7 d. On day 7, blast cells were
enriched by Ficoll-Hypaque density gradient centrifugation and were cultured at concentra-
tions of 30, 10, 3, and 1 cell/well with -y-irradiated (3,000 rad) autologous PBMC (105) in
0.2 ml RPMI containing10% human AB serum, 10% IL-2 (Cellular Products, Inc., Buffalo,
NY), and dengue 3 antigen at a final dilution of 1 :30 in 96-well round bottomed plates. On
day 14, 0.1 ml of medium was removed from each well and 105 -y-irradiated autologous
PBMC in 0.1 ml of fresh medium with human AB serum, IL-2, and dengue antigen was
added to maintain the same final concentrations described above. On day 21, cells in wells
demonstrating growth were transferred to 48-well flat-bottomed plates (Costar) and were fur-
ther cultured with 106 y-irradiated autologous PBMC in 1 ml of RPMI containing 10%
human AB serum, 10% IL-2, and dengue antigen at a dilution of 1 :30.
Proliferative Responses of T Cell Clones.
￿
104 T cells were cultured with 2 x 105 y-irradiatedKURANE ET AL.
￿
765
(3,000 rad) autologous PBMC in 0.2 ml RPMI containing 10 17o humanAB serum and dengue
3 antigen diluted at 1 :30 in 96-well round-bottomed plates at 37°C for 3 d. Cells were pulsed
with 1.25 p.Ci [3H]TdR for 8 h before harvest. They were harvested using a multiharvester
and [3H]TdR incorporation was counted in a liquid scintillation counter.
PhenotypicAnalysis.
￿
Anti-Leu-2 (CD8) antibody reacts with suppressor/cytotoxic T cells
(14). Anti-Leu-3 (CD4) antibody reacts with helper/inducer T cells (14). Anti-Leu-4 (CD3)
antibody reacts with pan T cells (15). Anti-Leu-2, -Leu-3, and -Leu-4 antibodies were pur-
chased from Becton Dickinson & Co. (Mountain View, CA). Clones were stained with mAbs
conjugated with FITC by direct immunofluorescence methods as described earlier (16). The
percentage of antigen-positive cells was determined using a FAGS (440; Becton Dickinson
& Co.).
Immunoassaysfor IFN-y.
￿
Sandwich-type ELISAs were used for the estimation of IFN-'r
activity as previously reported (9). Purified rabbit polyclonal anti-recombinant human IFN-
y (17) was coated on U-bottomedwells ofpolyvinyl chloride microtiter plates (Dynatech R/D
Co., Cambridge, MA). After washing, serial dilutions ofhuman IFN-y standard (British stan-
dard 82/587; 3,000 IU/ampule) or culture fluidsampleswere added. Then, purified anti-human
IFN-y mAb 4SB3 (18) was added. Color was developed usingbiotinylated sheep anti-mouse
Ig (Amersham International, Amersham, UK) and streptavidin biotinylated horseradish per-
oxidase complex (Amersham International). Levels of IFN-y in culture fluid samples were
interpolated from the IFN-y standard calibration curve. The detection limit of the IFN-y-
specific ELISA was 0.5 IU/ml.
Preparation ofCell Lines Pulsed with DengueAntigens.
￿
Lymphoblastoid cell lines (LCL) were
established by infecting PBMC with EBV from an infected marmoset cell line supernatant
as described (19). All the transformed cells were cultured in RPMI containing 10% FCS.
EBV was provided by Dr. Takeshi Sairenji of University of Massachusetts Medical Center.
4 x 105 LCL were incubated with dengue and yellow fever antigens at final dilution of
1 :100 in 1 ml RPMI containing10% FCS for 16 h. Cells were washed twice with RPMI/10%
FCS, "Cr-labeled, and used as target cells.
Preparation ofDengue 2 Virus-infectedLCL.
￿
5 x 105 LCL were infected with dengue 2 virus
at an m.o.i. of 5 PFU/ml for 2 h at 37°C, and resuspended in 5 ml ofRPMI/10% FCS. These
cells were maintained for 3-4 wk and examined for cytoplasmic dengue antigens using FA
staining (12). When the percentage of dengue antigen-positive cells was >50%, they were
used as target cells.
Cytotoxicity Assays.
￿
Target cells (0.5-2 x 106) were labeled with 0.5 MCi of 5'Cr (Na2CrO4)
(New England Nuclear, Boston, MA) in 0.2 ml of RPMI containing 10% FCS at 37°C for
60 min. Labeled cells were washed three times and suspended at 2.5 x 104/ml in RPMI/10%
FCS. 2.5 x 103 cells in 0.1 ml were added to each well in round-bottomed microtiter plates
(Linbro Chemical Co., Hamden, CT). Various concentrations of effector cells in 0.1 ml of
RPMI/10% FCS were added to each well to give the described E/T ratios. After incubation
at 37'C for 4 h, the supernatant fluid was collected from each well and counted in an auto-
matic gamma counter. The percent specific "Cr release was calculated by the formula:
100 x (cpm experimental release - cpm spontaneous release)/(cpm maximal release - cpm
spontaneous release).
Antibody Blocking ofthe Lysis ofDengue 2-infected Target Cells.
￿
mAbs OKIal, B7/21.7, and
S3/4 recognize HLA DR, DP, and DQdeterminants, respectively. mAb W6/32 recognizes
a framework determinant of HLA-A, -B, and -C. B7/21.7 and S3/4 were kindly provided
by Dr. Nancy Reinsmoen of University of Minnesota, Minneapolis, MN. OKIal and W6/32
were provided by Dr. John Sullivan of University of Massachusetts Medical Center. 2.5 x
103 "Cr-labeled target cells in 0.1 ml were incubated with 0.05 ml of 1 :20 diluted mAbs for
30 min. The effector cells were then added in 0.05 ml and incubated for 4 h. The percentage
of specific "Cr release was determined as described above.
Results
Proliferative Responses of Donor A PBMC to Dengue Antigens in a Bulk Culture.
￿
The
PBMC from donor A, who had been infected 1 yr earlier with dengue virus type766
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3, were cultured with dengue antigens offour serotypes, and [3H]TdR incorpora-
tion was examined. PBMC from this donor responded to dengue 3 antigen, and
they also responded to dengue 1, 2, and 4 antigens to lower but significant levels.
PBMC from donor B, who had been infected with dengue 1 virus -4 mo earlier,
responded best to dengue 1 antigen and also responded to dengue antigens ofother
serotypes to lower levels (Table I). These results indicate that T cell proliferation
in bulk culture after infection with one serotype ofdengue virus is primarily sero-
type specific, but also contains serotype crossreactive memory responses.
Establishment of CD4' T Cell Clones that Respond to Dengue 3 Antigen.
￿
We tried to
establish dengue-specific T cell clones by a limiting dilution method using lympho-
cytes from donor A and dengue 3 antigen. 12 clones were established that respond
todengue 3 antigen, but notto control antigen. All the clones were established from
wells containing 1 cell/well. The cloning efficiency was 15% with 1 cell/well, 48%
with 3 cells/well, 90% with 10 cells/well, and 100% with 30 cells/well. The clonality
of the clones used in the experiments was >96%.
Phenotypic analysis of the clones using mAbs showed that all the clones have
CD3+, CD4+ and CD8- phenotypes (Table II).
Serotype Specificity ofthe Dengue-specific TCell Clones.
￿
These clones were examined
for serotype specificity using dengue antigens offour serotypes and yellow feveran-
tigen. A dose-response study using cloneJK31 indicated that each ofthe antigens
induced maximum proliferative responses at a 1:30 dilution (data not presented).
Eight clones responded to dengue 1, 2, and 4 antigens to about the same level as
to dengue 3 antigen (Table III), and therefore, they are dengue serotype crossreac-
tive. Three of these serotype crossreactive clones (JK27, JK32, and JK35) also
responded toyellow fevervirusantigens. Four otherclones responded predominantly
to dengue 3 antigens, although there are some minor responses to other serotypes;
therefore, they are serotype specific.
Production ofIFN-y by Dengue-speck T Cell Clones after Stimulation with Dengue An-
TABLE I
Proliferation Responses of the PBMC of Donor A to
Dengue Antigens in Bulk Cultures
2 x 105 PBMC were cultured with dengue and control antigens diluted at 1 :30
for 6 d. Cells were pulsed with 1.25 jACi [3H]TdR for 8 h and [3H]TdR in-
corporation was counted.
" Donor A was known to have been infected with dengue 3 virus.
Donor B was known to have been infected with dengue 1 virus.
S Donor C is from Massachusetts and does not possess any antidengue antibodies.
Antigens Donor A"
[3H]TdR Incorporation
Donor Bt Donor C§
C11M
Dengue 1 5,128 15,932 481
Dengue 2 6,643 5,983 516
Dengue 3 25,177 6,772 682
Dengue 4 2,883 4,329 603
Control 660 1,065 460
No antigen 707 1,091 450KURANE ET AL.
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TABLE II
Phenotypic Analysis of Dengue Virus Antigen-speck T Cell Clones
Clones were stained with anti-CD3 (anti-Leu-4), anti-CD4 (anti-Leu-3), and
anti-CD8 (anti-Leu-2) mAbs. The percentage of positive cells was counted on
a FACS .
tigens.
￿
We have reported that IFN--y augments dengue virus infection of human
monocytic cells in thepresence ofantidenguevirus antibody (10), andhave hypothe-
sized that IFN-y may contribute to the pathogenesis of DHF/DSS (9, 10).
The dengue-specific clones were examined for INFy production after stimula-
tionwith dengue and yellow feverantigens (Table IV). All the serotype crossreactive
TABLE III
Proliferative Responses of Dengue Virus Antigen-speck T Cell Clones
to Dengue and Yellow Fever Antigens
104 cells were cultured with 2 x 105,y-irradiated autologous PBMC in 0.2 ml RPMI/10%
human AB serum containing dengue, yellow fever, and control antigens diluted at 1 :30 for
72 h. Cells were pulsed with 1 .25 ACi [3H]TdR for 8 h before harvest.
Serotype Clones
Dengue
1
Dengue
2
[3H]TdR Incorporation
Dengue Dengue Yellow
3 4 fever
Control
antigen
No
antigen
cpm
Crossreactive JK26 1,438 2,078 2,375 1,394 641 436 708
JK27 6,683 5,711 11,728 3,839 1,880 827 650
JK28 1,949 2,286 2,600 1,681 788 684 633
JK32 1,416 3,290 4,102 2,410 1,925 133 245
JK33 4,530 8,152 12,756 6,286 3,070 1,161 1,949
JK34 2,651 8,457 9,256 4,253 1,910 480 1,076
JK35 3,507 4,372 6,260 5,025 3,854 2,403 1,290
JK36 1,732 13,159 15,055 7,167 903 140 1,225
Specific JK24 2,581 2,205 13,809 1,457 355 348 108
JK30 821 896 3,246 721 276 112 218
JK31 745 1,269 7,309 837 397 140 133
JK37 4,478 6,958 26,892 5,827 2,546 1,223 1,985
Clones CD3
Percent antigen-positive cells
CD4 CD8
JK24 97 96 1
JK26 94 96 2
JK27 97 95 0.4
JK28 93 96 0.4
JK30 98 85 0.8
JK31 99 99 0.2
JK32 99 96 3
JK33 97 95 0.2
JK34 98 92 4
JK35 99 98 4
JK36 80 94 2
JK37 98 96 1768
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TABLE IV
IFN-y Production by Serotype Crossreactive T Cell Clones
after Stimulation with Dengue Antigens
104 cells were cultured with 2 x 105 -y-irradiated autologous PBMC in 0.2 ml
RPMI/10% human AB serum containingdengue, yellow fever, andcontrol an-
tigens diluted at 1 :30 for 72 h. Culture fluids were collected and assayed for IFN-y
by ELISA.
clones produced IFN-y after stimulation with dengue 3 antigen, and all butJK27
produced IFN-y to the same or lower levels after stimulation with dengue antigens
of the other serotypes. CloneJK35, which responded to yellow fever antigen, pro-
duced IFN-y after stimulation with yellow fever antigen. Serotype-specific clones
producedIFN-y afterstimulationwithdengue 3 antigen (data notpresented). These
results suggest that IFN-y is produced by serotype crossreactive T cells during sec-
ondary infections with different serotypes ofdengue virus from primary infections.
CytotoxicActivities ofDengue-speck TCell Clones to Autologous LCL Pulsed with Dengue
Antigens. Two serotype crossreactive clones, JK34 and JK36, were examined for
cytotoxic activity against autologous LCL pulsed with dengue and yellow fever an-
tigens. They lysed dengue 3 antigen-pulsed LCL and also lysed LCL pulsed with
dengue antigens ofotherserotypes (Table V).JK36, which did not proliferate after
TABLE V
Cytotoxic Activities of Dengue Virus-speck T Cell Clones
to Autologous LCL Pulsed with Dengue Antigens
2 .5 x 103 target cells were incubated with effector cells for 4 h. Percent specific
5tCr release was calculated by the formula described in Materials and Methods.
E/T ratio was 6:1 for JK34, 5:1 for JK36, and 2 :1 for JK37.
Clones
Dengue
1
Dengue
2
Dengue
3
IFN-y
Dengue
4
Yellow
fever
Control
antigen
No
antigen
U/mt
JK26 26 74 39 19 9 6 7
JK27 7 6 35 4 3 3 3
JK28 13 14 13 6 2 1 <1
JK32 12 23 18 11 6 3 3
JK33 14 24 41 17 8 2 5
JK34 6 22 23 10 4 2 3
JK35 17 33 51 21 10 <1 3
JK36 2 15 18 7 2 3 <1
Autologous LCL
pulsed with antigen JK34
Percent specific 51Cr release
JK36 JK37
Dengue 1 24 0 1
Dengue 2 51 42 0
Dengue 3 52 43 18
Dengue 4 43 24 0
Yellow fever 0 1 0
Control 0 0 0
None 0 0 0stimulation with dengue 1 antigen, did not lyse dengue 1 antigen-pulsed LCL. A
serotype-specificclone, JK37, lysed dengue 3 antigen-pulsed LCL, but didnot lyse
theothertarget cells. Theseresultsindicate that dengue-specific clones have dengue
antigen-specific cytotoxicactivities and serotype crossreactivity in cytotoxicityis con-
sistent with the responses observed in proliferation assays.
Time Course andDose-Response Studies ofthe Lysis ofDengue 2-infected Cells by a TCell
Clone. We then used dengue 2 virus-infected autologous LCL as target cells in
cytotoxic assays. A time course study usingJK32 as effector cells showed that low
levels oflysis were observed as early as 2 h, and the percentage oflysis reached al-
most maximum levels by 4 h (Fig. 1). Significant lysis oftarget cells by cloneJK32
was observed even at an E/T ratio of0.3 (Table VI). JK32 did not lyse uninfected
autologous LCL or K562 cells, which are sensitive target cells for human NK cells.
Lysis ofDengue 2 Virus-infected Autologous Lymphoblastoid CellLine by Dengue Serotype
Crossreactive T Cell Clones, We examined other clones for their cytotoxic activities
to dengue 2 virus-infected autologous LCL. All the crossreactive clones but one
(JK27) lysed dengue 2 virus-infected autologous LCL (Table VII). These clones
did not lyse uninfected LCL or K562 cells. Dengue 3 serotype-specific clones did
not lyse dengue 2-infected LCL, uninfected LCL, or K562. These results suggest
that serotype crossreactive T cells may lyse dengue-infected cells during secondary
infections.
HLA Class IIAg-restricted Lysis of Target Cells by T Cell Clones.
￿
HLA restrictions
ofthe lysisoftarget cellsby dengue-specific Tcell clones were examined usingmAbs
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FIGURE 1.
￿
Time course of the lysisof dengue 2-infected autolo-
gous LCLbyJK32. Thelysis ofdengue 2-infected and uninfected
autologous LCLbyJK32 wasexamined at various times. E/Tratio
was2:1 . (O)Dengue 2-infected autologous LCL; (")uninfected
autologous LCL.
TABLE VI
Effector-Target Cell Dose-Response Study of the Lysis of
Dengue 2 Virus-infected Cells by JK32
5 x 103 target cellswere incubatedwith various numbers of effector cells for4h.
E/T ratio
Percent
Dengue 2-infected
autologous LCL
specific "Cr release
Uninfected
autologous LCL K562
10 60 5 1
3 57 1 1
1 49 0 0
0.3 28 0 0770
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TABLE VII
Lysis of Dengue 2 Virus-infected Autologous LCL
by Serotype Cross-reactive T Cell Clones
2.5 x 103 target cells were incubated with effector cells for 4 h. Percent specific
5'Cr release was calculated by the formula described in Materials and Methods.
to HLA antigens. Anti-HLA DP mAb 117/21.7 inhibited the lysis ofdengue 3 an-
tigen-pulsed autologous LCLanddengue 2virus-infected autologous LCLbyJK32,
JK34, andJK35. Anti-HLA DQmAb S3/4 inhibited the lysis ofthese target cells
byJK36 (Table VIII). Anti-HLA class I mAb W6.32 did not inhibit the lysis of
target cells by these T cell clones (data not presented). These results indicate that
dengue-specific CD4+ T cell clones lyse target cells in an HLA class 11-restricted
fashion, andthat HLA DP or DQantigens are therestrictingantigens for theclones
examined.
TABLE VIII
HLA Class II Antigen-restricted Lysis of Target Cells
by Dengue-speck T Cell Clones
2.5 x 103 target cells were incubated with 1 .25 x 104 effector cells for 4 h in
the presence of mAbs, at final dilution of 1:80.
OKIal, 117/21 .7, and S3/4 were used as anti-HLA DR, anti-HLA DP, and
anti-HLA DQ antibodies, respectively.
Serotype Clones
E/T
ratio
Percent
Dengue 2-infected
autologous LCL
specific 5'Cr release
Uninfected
autologous LCL K562
Crossreactive JK26 2 71 0 0
JK27 2 0 0 0
JK28 2 85 0 0
JK32 2 42 2 0
JK33 2 16 0 1
JK34 2 43 0 0
JK35 2 35 0 1
JK36 2 59 0 0
Specific JK30 3 0 0 0
JK31 3 0 0 0
JK37 4 2 2 0
Target cells mAbs
Percent specific
JK32 JK34
5'Cr
JK35
release
JK36
Dengue 3 antigen-pulsed
autologous LCL - 81 73 22 83
HLA DR 92 77 30 72
HLA DP 6 5 2 70
HLA DQ 78 79 27 9
Dengue 2 virus-infected
autologous LCL - 54 57 22 44
HLA DR 56 57 19 41
HLA DP 4 8 2 50
HLA DQ 45 59 22 8KURANE ET AL.
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Discussion
In this paper we report the establishment of dengue antigen-specific human T
cell clones and describe the serotype specificity, IFN-'y production, and cytotoxic
activity of these T cell clones. Dengue antigen-specific T cell clones were estab-
lished from the PBL of a donor who had been infected with dengue 3 virus. All
of the clones have a CD3 - CD4+ CD8- phenotype. 8 of 12 clones responded to
dengue antigens in a serotype crossreactive fashion. Four of the clones, which we
called serotype-specific type, responded predominantly to dengue 3 antigen. Prolifer-
ative responses in bulk cultures of the PBMC of this donorwere primarily dengue
3 serotype-specific, but also contained serotype crossreactiveresponses to lower levels.
Therefore, the serotype crossreactive responses observed in bulk cultureexperiments
appear to reflect the crossreactive responses detected at the clonal level.
Epidemiological studies have shown that the severe complications of dengue, DHF
andDSS, are much more commonly observed during secondary infections than pri-
mary infections, and that secondary infections are caused by a different serotype
of dengue virus from primary infection (1, 8). Therefore, these results, which dem-
onstrate that most of the dengue-specific T cell clones are serotype crossreactive,
support thepossibility that dengue crossreactive T cells will be activated during sec-
ondary infections with a virus of aheterologous serotype and that these T cells may
contribute to the pathogenesis of DHF/DSS.
Cytotoxic functions of these T cell clones were examined using dengue 2
virus-infected autologous LCL because epidemiological studies in Thailand have
shown that secondaryinfections with dengue 2 virus inducedhigher ratesofDHF/DSS
than did secondary infections with the other serotypes of dengue virus (8). All but
one serotype crossreactive clone lysed dengue 2-infected autologous LCL. These
clones did not lyse uninfected LCL or K562 cells. The lysis ofdengue-infected cells
by the clones examined was inhibited by anti-HLA DP and anti-DQ antibodies;
therefore, these serotype crossreactive cytotoxic T cell clones are HLA class II re-
stricted. It is known that monocytes are the cells that best support dengue virus in-
fection(20), andmonocytic cellswith dengue antigens have been observed in DHF/DSS
patients (5, 6). It hasbeen hypothesized that lysis of dengue-infected monocytes may
lead to DHF/DSS (1). Therefore, it is important to learn whether these serotype
crossreactive CTL clones can lyse dengue 2 virus-infected autologous monocytes.
Two ofthe serotype crossreactive clones we have examined to date lysed dengue type
2 virus-infected autologous monocytes, but they did not lyse uninfected monocytes
(data not presented).
We have previously reported that CD4+ dengue-specific T lymphocytes
proliferate and produce IFN--y after stimulation with dengue antigens in bulk cul-
tures (9). We have also reported that IFN-y increases the number of Fc-y receptors
on human monocytic cell line and monocytes (21, 22), and that this results in aug-
mented dengue virus infection in the presence of antidengue antibodies (10). There-
fore, it was important to learn whetherdengue-specific Tcell clones produce IFN-1'
after stimulationwith heterologous dengue virus antigens. Ourresultsdemonstrated
that most of theserotype crossreactive Tcell clones produceIFN-'Y after stimulation
with dengue antigens of other subtypes, which is consistent with our previous ex-
periments in bulk cultures (9).
Based on these observations we hypothesize roles for dengue-specific T lympho-772
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cytes in the pathogenesis of DHF/DSS. Dengue serotype crossreactive CD4' T lym-
phocytes are activated and produce IFN-'Y during secondary infection with a virus
strain of a heterologous serotype. IFN-.y increases the number of Fcy receptors of
monocytes, and this augments dengue virus infection of monocytes in the presence
ofantidengue antibodies. IFN-,yalso increasesHLA classII antigen expression (23),
andactivatesmonocytes to produce inflammatory mediators, which may contribute
to the pathogenesis of DHF/DSS. Dengue-infected, IFN-y-activated monocytes are
then lysed by dengue serotype crossreactive CD4' T lymphocytes, and mediators
will be quickly released from these monocytes, which may lead to DHF/DSS.
Although our results support the contribution of dengue-specific CD4' T lym-
phocytes in the pathogenesis ofDHF/DSS during secondary infections, they do not
explain thepathogenesis ofDHF/DSS in primary infections. DHF/DSS, which occurs
during primary infections, consists of<1% of the cases ofDHF/DSS (24), and most
of these occur as primary infections of infants from 6 to 12 mo of age born to the
dengue antibody-positive mothers (1, 8). Kliks et al., (25) recently reported that levels
ofmaternal antibody correlated with theoccurrence of DHF/DSS ofthe infants during
their first year.
We have recently detected CD4- CD8+ dengue virus-specific T lymphocytes.
They lyse dengue virus-infected autologous cellsin an HLA classI-restricted fashion
(Bukowski, J., I. Kurane, and F. A. Ennis, manuscript in preparation). Theseresults
indicate that there are two types of dengue-specific CTL; CD4' CD8- HLA class
II-restricted CTL described in this report and CD4- CD8* HLA class I-restricted
CTL. The role of these CTL in the pathogenesis of and in recovery from dengue
infections are important subjects to be elucidated.
Mapping of theepitopes that are recognized by theseTcell clones is an important
task. We have observed that spleen cells from mice immunized with dengue virus
proliferate after stimulation with baculovirus-dengue constructs expressing dengue
structural and nonstructural proteins (26). Dengue protein constructs prepared by
recombinant DNA techniques and synthetic peptides will be used for defining the
epitopes that are recognized by these dengue antigen-specific T cell clones. Defini-
tion of the epitopes recognized by dengue-specific Tcell clones and theMHC haplo-
types that restrict these responses will give useful information for attempting devel-
opment of subunit vaccines against dengue virus infections.
Summary
The severe complications of dengue virus infections, hemorrhagic manifestation
and shock, are much more commonly observed during secondary infections caused
by a different serotype of dengue virus than that which caused the primary infec-
tions. It has been speculated, therefore, that dengue hemorrhagic fever (DHF) and
dengue shock syndrome (DSS) are caused by serotype crossreactive immunopatho-
logical mechanisms. We analyzed clones of dengue serotype crossreactive T lym-
phocytes derived from the PBMC of a donor who had been infected with dengue
3 virus. These PBMC responded best to dengue 3 antigen, but also responded to
dengue 1, 2, and 4 antigens, in bulk culture proliferation assays. 12 dengue an-
tigen-specific clones were established using a limiting dilution technique. All of the
clones had CD3+ CD4' CD8- phenotypes. Eight clones responded to dengue 1, 2,
3, and 4 antigens and are crossreactive, while four otherclones responded predomi-nantly to dengue 3 antigen. These results indicate that the serotype crossreactive
dengue-specific T lymphocyteproliferation observed in bulk cultures reflects the cross-
reactive responses detected at the clonal level.
Serotype crossreactive clones produced high titers ofIFN-y after stimulation with
dengue 3 antigens, and also produced IFN-y to lower levels after stimulation with
dengue 1, 2, and 4 antigens. The crossreactive clones lysed autologous lymphoblastoid
cell line (LCL) pulsed with dengue antigens, and the crossreactivity of CTL lysis
by T cell clones was consistent with the crossreactivity observed in proliferation assays.
Epidemiological studies have shown that secondary infections with dengue 2 virus
cause DHF/DSS at a higher rate than the other serotypes. We hypothesized that
the lysis of dengue virus-infected cells by CTL may lead to DHF/DSS; therefore,
the clones were examined for cytotoxic activity against dengue 2 virus-infected LCL.
All but one of the serotype crossreactive clones lysed dengue 2 virus-infected autol-
ogous LCL, and they did not lyse uninfected autologous LCL. The lysis of dengue
antigen-pulsed or virus-infected LCL by the crossreactive CTL clones that we have
examined is restricted by HLA DP or DQ antigens.
These results indicate that primary dengue virus infections induce predominantly
crossreactive memory CD4+ T lymphocytes. These crossreactive T lymphocytes
proliferate and produce IFN-y after stimulation with a virus strain of another sero-
type, and demonstrate crossreactive cyotoxic activity against autologous cellsinfected
with heterologous dengue viruses. Based on these results we hypothesize that dengue
serotype crossreactive T lymphocytes may contribute to the pathogenesis ofDHF/DSS:
(a) by producing IFN-y, which increases the number of Fcy receptors and subse-
quently increases the number ofdengue-infected cellsby enhanced uptake of dengue
virus-antibody complexes; and (b) by lysing dengue virus-infected cells during sec-
ondary infections with a virus of the heterologous serotype.
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